İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023 · article

Incidence of cereblon protein in intensive care patients: a cross-sectional study.

Dergi Eur Rev Med Pharmacol Sci. ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.
ISSN2284-0729
YÖKSİS OpenAlex
Yıl2023
Atıf1OpenAlex
Yüzdelik%40,5
FWCI0,091,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q2

Veri kaynağı ayrımı

  • YÖKSİSYÖKSİS makale kaydı
  • YÖKSİS dergi adıEur Rev Med Pharmacol Sci.
  • Katalog eşleşmesi (ISSN)European Review for Medical and Pharmacological Sciences (discontinued)
  • OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
  • Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)

Özet

OpenAlex İngilizce

OBJECTIVE: Sepsis remains a common cause of death. The cereblon (CRBN) protein, which is involved in important cellular processes, plays a role in sepsis. This cross-sectional study aimed to show the CRBN protein expression and its effects on patients in the intensive care unit. PATIENTS AND METHODS: Samples were taken by deep tracheal aspiration from patients. The presence of CRBN was pathologically investigated using immunohistochemical tests and polyclonal antibodies against CRBN. The relationship between gender, sepsis, steroid, survival and the presence of CRBN was examined. RESULTS: Respiratory and neurologic diseases were the most common reasons for admission. Acinetobacter was the most frequent microorganism. In patients with more than normal inflammatory cells, a negative correlation was observed between CRBN expression and leukocyte rate (p=0.031). In patients with CRBN, there was no correlation between steroid and mortality, APACHE/Glasgow score, hospital stay length, and ICU. CONCLUSIONS: Although the prognosis for sepsis is better in CRBN-deficiency animals, the presence of CRBN in humans does not affect it. In our study, CRBN decreased as inflammatory cells increased in the patient's aspiration material. The response to steroids, an immunomodulator, did not change with the presence of the immunomodulator target molecule, CRBN. Therefore, using immunomodulators in the treatment of sepsis should be reconsidered.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

1atıfOpenAlex · cited_by_count (önbellek / veritabanı)

Yazarlar

8
  1. PINAR AYVAT 1
  2. AYŞE GÜLDEN DİNİZ ÜNLÜ İZMİR DEMOKRASİ ÜNİVERSİTESİ 2
  3. HAKAN GÜLMEZ 3
  4. DERYA ARSLAN YURTLU 4
  5. Kamil Aşar 5
  6. KAAN KATIRCIOĞLU 6
  7. CEM ECE 7
  8. ZEYNEP SOFUOĞLU İZMİR DEMOKRASİ ÜNİVERSİTESİ 8